Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

,thrombopoietin-receptor agonists(TPO-RA) ,bortezomib or splenectomy,have been largely unsatisfactory. As we know, HLA antibodies are mainly secreted by the plasma cells. Researchers want to see if sequential

  • 0 views
  • 06 Nov, 2021
  • 1 location
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

To evaluate the safety and efficacy of zanubrutinib in the treatment of antiphospholipid syndrome with secondary thrombocytopenia in 10 patients.

rituximab
cyclophosphamide
cyclosporine
  • 0 views
  • 09 Jun, 2022
  • 2 locations
French Adult Primary Immune Thrombocytopenia (FAITH)

thrombopoietin-receptor agonists since 2009. The compared efficacy and safety on clinical events in the long-term are unknown. The main objective of the FAITH study is to build the cohort of all treated adult

splenectomy
autoimmune thrombocytopenia
  • 3 views
  • 26 Feb, 2022
  • 1 location